Attached files

file filename
EX-14.1 - EX-14.1 - BIOCEPT INCd697720dex141.htm
EX-31.1 - EX-31.1 - BIOCEPT INCd697720dex311.htm
EX-31.2 - EX-31.2 - BIOCEPT INCd697720dex312.htm
10-K - FORM 10-K - BIOCEPT INCd697720d10k.htm
EX-32.2 - EX-32.2 - BIOCEPT INCd697720dex322.htm

EXHIBIT 32.1

CERTIFICATION

I, Michael W. Nall, hereby certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that, to my knowledge, the Annual Report on Form 10-K of Biocept, Inc. for the fiscal year period ended December 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Biocept, Inc.

 

   
Date: March 28, 2014     /s/ Michael W. Nall
    Michael W. Nall
   

President and Chief Executive Officer

(Principal Executive Officer)

This certification accompanies the Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.